CIA
ABBV icon

Citadel Investment Advisory’s AbbVie ABBV Stock Holding History

Citadel Investment Advisory’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.49M Sell
17,848
-10
-0.1% -$2.15K 2.04% 11
2026
Q1 		$3.88M Sell
17,858
-433
-2% -$96K 1.85% 11
2025
Q4 		$4.18M Hold
18,291
– – 1.81% 12
2025
Q3 		$4.24M Sell
18,291
-25
-0.1% -$5.09K 1.94% 12
2025
Q2 		$3.4M Sell
18,316
-140
-0.8% -$26K 1.65% 14
2025
Q1 		$3.87M Buy
18,456
+75
+0.4% +$14.6K 1.9% 10
2024
Q4 		$3.27M Buy
18,381
+2,137
+13% +$393K 1.69% 12
2024
Q3 		$3.21M Buy
16,244
+400
+3% +$74.7K 1.69% 13
2024
Q2 		$2.72M Hold
15,844
– – 1.55% 13
2024
Q1 		$2.88M Sell
15,844
-235
-1% -$40.5K 1.63% 13
2023
Q4 		$2.49M Hold
16,079
– – 1.53% 15
2023
Q3 		$2.4M Hold
16,079
– – 1.57% 14
2023
Q2 		$2.17M Sell
16,079
-325
-2% -$47.7K 1.4% 18
2023
Q1 		$2.61M Sell
16,404
-350
-2% -$53.5K 1.78% 14
2022
Q4 		$2.71M Sell
16,754
-190
-1% -$29.1K 1.85% 13
2022
Q3 		$2.27M Buy
16,944
+200
+1% +$28.7K 1.73% 15
2022
Q2 		$2.56M Sell
16,744
-600
-3% -$91.7K 1.74% 14
2022
Q1 		$2.81M Sell
17,344
-242
-1% -$35.2K 1.63% 13
2021
Q4 		$2.38M Hold
17,586
– – 1.39% 20
2021
Q3 		$1.9M Hold
17,586
– – 1.18% 21
2021
Q2 		$1.98M Sell
17,586
-300
-2% -$33.8K 1.22% 20
2021
Q1 		$1.94M Buy
17,886
+11,450
+178% +$1.22M 1.27% 20
2020
Q4 		$690K Buy
+6,436
New +$618K 0.49% 49

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Citadel Investment Advisory's ABBV Position: Q2 2026 in Review

Citadel Investment Advisory reduced its AbbVie (ABBV) stake by 0.06% in Q2 2026, selling an estimated $2.15K and leaving 17,848 shares worth $4.49M. The position accounts for 2.04% of the portfolio, ranked #11.

Citadel Investment Advisory first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Citadel Investment Advisory held 17,848 shares of AbbVie worth $4.49M as of Q2 2026.
  • Citadel Investment Advisory sold 10 AbbVie shares in Q2 2026, an estimated $2.15K.
  • AbbVie made up 2.04% of Citadel Investment Advisory's portfolio in Q2 2026, its #11 holding.
  • Citadel Investment Advisory first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Citadel Investment Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.